# Comparison of Nebulized Ketamine to Intravenous Sub-Dissociative Dose Ketamine for Pain

> **NCT04947085** · PHASE4 · COMPLETED · sponsor: **Antonios Likourezos** · enrollment: 150 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Ketamine via Intravenous
- **DRUG:** Ketamine via BAN

## Key facts

- **NCT ID:** NCT04947085
- **Lead sponsor:** Antonios Likourezos
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-04
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-12-31
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04947085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04947085, "Comparison of Nebulized Ketamine to Intravenous Sub-Dissociative Dose Ketamine for Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04947085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*